6/11/2024
to
Houston
Advancing cancer immunotherapy through research, education, and collaboration.
Strategic alliance based in the Edinburgh BioQuarter provides clients with richer data analysis, driving smarter, data-driven decisions
The UK's thriving biotech and pharmaceutical sector continues to drive ground breaking advances in medical innovation, yet many companies may be overlooking valuable financial support available through R&D tax credits.
Balancing Flexibility With Control
In vitro assays for your chemical or agrochemical regulatory submission
Accelerate your design, make, test cycle with leading in vitro ADME & in vivo DMPK
Revolutionize your Hit ID with Biopals
A guide to choosing the right tumour cell killing assay
We are pleased to announce that Dr Ralph Kirk (Associate Director) has joined the Peptide Drug Hunting Consortium, Strengthening Innovation in Peptide Drug Discovery. His inclusion in this elite network is a testament tohis deep scientific expertise and long-standing contribution to medicinal chemistry.